On August 1, 2024, Apollomics Inc., a foreign private issuer, filed a Form 6-K with the United States Securities and Exchange Commission, announcing executive changes as part of its strategic focus and cost reduction efforts. The company disclosed that Sanjeev Redkar, Ph.D., co-founder and President, along with Peony Yu, M.D., Chief Medical Officer, have stepped down from their positions. Both executives are transitioning to consulting roles, with Dr. Redkar continuing to serve on the Board of Directors. The announcement was made official by the signature of CEO Guo-Liang Yu.

On August 1, 2024, Apollomics Inc., a foreign private issuer, filed a Form 6-K with the United States Securities and Exchange Commission, announcing executive changes as part of its strategic focus and cost reduction efforts. The company disclosed that Sanjeev Redkar, Ph.D., co-founder and President, along with Peony Yu, M.D., Chief Medical Officer, have stepped down from their positions. Both executives are transitioning to consulting roles, with Dr. Redkar continuing to serve on the Board of Directors. The announcement was made official by the signature of CEO Guo-Liang Yu.